Comparison

NVS-CECR2-1 European Partner

Item no. TMO-T37151-50mg
Manufacturer TargetMol
CASRN 1992047-61-6
Amount 50 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles O=S(=O)(C1=NC(=CC(=N1)C2=CC=C3C(C=CN3C4CC(NC(C)(C)C4)(C)C)=C2)NC5CC5)CCC
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis|||CDK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
495.68
Description
NVS-CECR2-1 is a selective cat eye syndrome chromosome region candidate 2 (CECR2) inhibitor with antitumor activity and inhibits chromatin binding of CECR2 BRD. NVS-CECR2-1 is cytotoxic and can induce apoptosis.
Pathways
Cell Cycle/Checkpoint|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close